A k-mer based transcriptomics approach for antisense drug discovery targeting the Ewing's family of tumors.

Annalora, Andrew J; O'Neil, Shawn; Bushman, Jeremy D; Summerton, James E; Marcus, Craig B; Iversen, Patrick L

Annalora, Andrew J; O'Neil, Shawn; Bushman, Jeremy D; Summerton, James E; Marcus, Craig B; Iversen, Patrick L.

Afiliación

Annalora AJ; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.
O'Neil S; Center for Genome Research and Biocomputing, Oregon State University, Corvallis, OR 97331, USA.
Bushman JD; Onco-Tools, LLC, Philomath, OR 97370, USA.
Summerton JE; Onco-Tools, LLC, Philomath, OR 97370, USA.
Marcus CB; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.
Iversen PL; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.

Oncotarget ; 9(55): 30568-30586, 2018 Jul 17.

Article en En | MEDLINE | ID: mdl-30093970

Palabras clave

Ewing's family of tumors; RNA-based therapeutics; antisense oligonucleotides; phosphorodiamidate morpholino oligomers; transcriptomics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google